Showing 2291-2300 of 10622 results for "".
Health-Related Quality of Life: How and Why Should We Measure It?
https://reachmd.com/programs/clinicians-roundtable/health-related-quality-of-life-how-and-why-should-we-measure-it/2954/Dr. Melanie Calvert, a research fellow at the University of Birmingham, PhD biochemist, and quality of life researcher speaks with host, Dr. Gary Kohn on quality of life measurement; how it's currently conducted and implemented in the medical field, and its future potential.Stem Cell Research: The Mouse Incisor Model
https://reachmd.com/programs/clinicians-roundtable/stem-cell-research-the-mouse-incisor-model/2896/Where do we stand with stem cell research, and what does the future hold for this controversial field of investigation? Host Dr. Bruce Bloom discusses stem cell research with Dr. Ophir Klein, of the Biomedical Sciences Graduate Program at the University of California, San Francisco.Emerging Biomarkers and New Drugs
https://reachmd.com/programs/lipid-luminations/emerging-biomarkers-and-new-drugs/2802/Host Dr. Larry Kaskel welcomes Dr. Michael Davidson, Director of Preventive Cardiology at the University of Chicago School of Medicine and Executive Medical Director of Radiant Research in Chicago. Dr. Davidson will discuss C-reactive protein (CRP) levels and other emerging biomarkers as well as newImplications of a Colorectal Cancer Family History
https://reachmd.com/programs/clinicians-roundtable/implications-of-a-colorectal-cancer-family-history/2672/Colon cancer is the second leading cause of cancer deaths in the United States. What are the hereditary conditions considered to be likely indicators of colon cancer in the patient, and what truly constitutes a complete family history of the disease? Dr. Lee Freedman speaks with Dr. Mark Pochapin,Insurance Coverage and Late Stage Cancer Diagnosis
https://reachmd.com/programs/clinicians-roundtable/insurance-coverage-and-late-stage-cancer-diagnosis/2671/Having low-quality health insurance, or a complete lack of insurance is certainly detrimental to patients' health; yet is there any hard data to properly correlate an association? Dr. Elizabeth Ward, from the American Cancer Society explores the relationship with Dr. Lee Freedman, citing a recent AManagement of Small Renal Tumors
https://reachmd.com/programs/clinicians-roundtable/management-of-small-renal-tumors/2634/Small Renal tumors: Are patients being properly counseled? With your host, Dr. Gary Kohn, is Robert "Houston" Thompson, Urologic Oncology Fellow, at Memorial Sloan Kettering Cancer Center in New York. Join the discussion as Dr. Thompson covers the management of small renal tumors, highlighting surviNon-Steroidal, Topical Anti-Inflammatories
https://reachmd.com/programs/clinicians-roundtable/non-steroidal-topical-anti-inflammatories/2598/Dr. Michael Greenberg interviews Dr. Mark Lebwohl, Professor of Dermatology from the Mount Sinai School of Medicine in New York. Dr. Lebwohl discusses Protopic, Elidel, the myths and realities behind their safety for patients.Identifying the Vague Symptoms of MS
https://reachmd.com/programs/clinicians-roundtable/identifying-the-vague-symptoms-of-ms/2551/Dr. John Richert describes the role of the office practice in this disease. Vague symptoms can be the first presentation of the relapsing-remitting form of this condition and lead to the appropriate tests and diagnosis. Here is where support for living with disability and frustations can be found.Hormone Therapy and Breast Cancer
https://reachmd.com/programs/clinicians-roundtable/hormone-therapy-and-breast-cancer/2541/Does hormone therapy bring with it an increased risk of breast cancer, or does it conversely lead to earlier detection of pre-existing tumors and thereby improve outcomes for these patients? Dr. Leon Speroff discusses the alleged findings of the Women's Health Initiative in this regard, and delves dData Mining: Perspectives from the AMA
https://reachmd.com/programs/clinicians-roundtable/data-mining-perspectives-from-the-ama/2522/An American Medical Assocation survey found a 66% disapproval rate amongst physicians in regards to Data Mining. What is it? And why are practitioners opposed? Dr. Jeremy Lazarus, a Colorado psychiatrist and Speaker of the American Medical Association House of delegates, discusses the design of the